Abstracts tagged "neuropeptides"

Abstract Number: 223 • 2019 ACR/ARP Annual Meeting
Correlation Between Heart Rate Variability Parameters and Circulating Neuropeptides in Fibromyalgia
Laura Aline Martínez-Martínez¹, Claudia Lerma Gonzalez ², María del Carmen Navarro Gonzalez ³, Oscar Infante Vázquez ⁴, Felipe Israel López Trejo ⁵, Evelyn Aranda Cano ⁵, Alfonso Salgado Aguayo ³, Daniel Paz Gómez ³, María Isabel Barrera Villalpando ⁶, Luis Silveira ⁷, Violeta Higuera Ortiz ⁸, Angélica Vargas Guerrero ⁵ and Manuel Martínez-Lavín ⁹, ¹Departamento de Reumatologia del Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, ²Departamento de Instrumentación del Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, ³Laboratorio de Investigación en Enfermedades Reumáticas del Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico, ⁴Departamento de Instrumentación del Instituto Nacional de Cardiología Ignacio Chávez, Mexico Ciity, Mexico, ⁵Departamento de Reumatología del Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, ⁶Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico, ⁷Departamento de Reumatología, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México., Mexico, Mexico, ⁸Hospital General de Zona y Medicina Familiar 8 del Instituto Mexicano del Seguro Social, Mexico City, Mexico, ⁹Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
Background/Purpose: Heart rate variability analyses in fibromyalgia patients have shown changes consistent with sympathetic hyperactivity that theoretically could lead to chronic pain. There is little…
Abstract Number: 2229 • 2017 ACR/ARHP Annual Meeting
The Effect of Intra-Articular Neurotoxin on Arthritis Pain and Substance P Expression in the Dorsal Root Ganglion: Results from Murine Arthritis Models
Hollis Krug^1,2, Sandra Frizelle³, Nicole Blanshan⁴, Christopher W. Dorman³ and Maren Mahowald^2,5, ¹Medicine, Minneapolis VAHCS, Minneapolis, MN, ²Medicine, University of Minnesota Medical School, Minneapolis, MN, ³Research, Minneapolis VA Health Care System, Minneapolis, MN, ⁴Research, Minneapolis VAHCS, Minneapolis, MN, ⁵Rheumatology/ Dept of Medicine, Minneapolis VA and Univ MN Med School, SAINT PAUL, MN
Background/Purpose : Substance P (SP) release and binding to NK-1 produces pain transmission. Neurotoxins (NT) that prevent release of SP, such as onabotulinum toxin (BoNT/A),…
Abstract Number: 1321 • 2013 ACR/ARHP Annual Meeting
Vasoactive Intestinal Peptide Serum Levels As a Marker Of Prognosis In Rheumatoid Arthritis
Rosario Garcia-Vicuña¹, Ana M. Ortiz², Iria Valino-Seoane³, Amalia Lamana¹, Javier Leceta³, Yasmina Juarranz³, Isidoro González-Alvaro², Rosa P Gomariz³ and Carmen Martinez-Mora⁴, ¹Rheumatology, Hospital Universitario de La Princesa. IIS Princesa, Madrid, Spain, ²Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, ³Cellular Biology, School of Biology. Universidad Complutense de Madrid, Madrid, Spain, ⁴Cellular Biology, School of Medicine. Universidad Complutense de Madrid, Madrid, Spain
Background/Purpose: The current shift to earlier treatment of Rheumatoid Arthritis (RA) has a major unmet need in the availability of biomarkers to identify patients requiring more…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].